Health economic modeling for Alzheimer's disease: Expert perspectives-Reference-Cited by-同舟云学术

Health economic modeling for Alzheimer's disease: Expert perspectives

Published:2022-01 Issue:1 Volume:8 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Landeiro Filipa¹,Morton Jasmine¹,Gustavsson Anders²³,Potashman Michele⁴,Lecomte Pascal⁵,Belger Mark⁶,Thompson Robin⁷,Roncancio‐Diaz Emilse⁸,Jhuti Gurleen⁹,Butler Christopher¹⁰,Jönsson Linus²¹¹,Handels Ron²¹²,Gray Alastair M.¹,

Affiliation:

1. Health Economics Research Centre Nuffield Department of Population Health University of Oxford Oxford UK

2. Division of Neurogeriatrics Department for Neurobiology Care Sciences and Society Karolinska Institutet Solna Sweden

3. Quantify Research Stockholm Sweden

4. Value and Access, Biogen Cambridge Massachusetts USA

5. Global Head Health Economic Modelling and Methodology Novartis Pharma AG Basel Switzerland

6. Global Statistical Sciences Eli Lilly and Company Windlesham UK

7. Biogen International GmbH Baar Switzerland

8. GE Healthcare Life Sciences Amersham UK

9. Global Access Centre of Excellence F. Hoffmannn‐La Roche Ltd. Basel Switzerland

10. Department of Brain Sciences Imperial College London London UK

11. H. Lundbeck A/S Valby Denmark

12. Faculty of Health Medicine and Life Sciences, Department of Psychiatry and Neuropsychology School for Mental Health and Neuroscience Alzheimer Center Limburg Maastricht University Medical Center Maastricht the Netherlands

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/trc2.12360

Reference27 articles.

1. Challenges in demonstrating the value of disease-modifying therapies for Alzheimer’s disease

2. Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment

3. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer’s Disease

4. Modelling Disease Progression in??Alzheimer???s Disease

5. Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dissonance in the face of Alzheimer's disease breakthroughs: clinician and lay stakeholder acceptance, concerns and willingness to pay for emerging disease-modifying therapies;The British Journal of Psychiatry;2024-04-17

2. New IPECAD open-source model framework for the health technology assessment of early Alzheimer’s disease treatment: development and use cases;2024-04-07

3. COVID-19: Experiences of Social Workers Supporting Older Adults With Dementia in Nigeria;INQUIRY: The Journal of Health Care Organization, Provision, and Financing;2024-01

4. Dementia and cognitive impairment in French-speaking Sub-Saharan Africa: a comprehensive review on moving out of the shadows of neglect;2023-05-04